Neuroblastoma cells can undergo neural differentiation upon treatment with a variety of chemical inducers and growth factors. During this process, many cell cycle-related genes are downregulated while differentiationspecific genes are triggered. The retinoblastoma family proteins, pRb, p107, and pRb
Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells
✍ Scribed by Raschell�, Giuseppe ;Tanno, Barbara ;Bonetto, Francesco ;Negroni, Anna ;Amendola, Roberto ;Paggi, Marco G.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 278 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
Background. The expression of several genes is modulated during neuroblastoma differentiation. The retinoblastoma family proteins, pRb, p107 and pRb2/p130, act in the repression of proliferation genes, interacting mainly with the E2F transcription factors. Procedure and Results. In this study, we found that, in neuroblastoma cell lines, pRb and p107 proteins decreased, undergoing progressive dephosphorylation, whereas pRb2/p130 increased at late stages of differentiation. B-myb expression was down-regulated in association with the up-regulation of pRb2/p130, the major partner of E2F on the E2F site of the B-myb promoter in differentiated cells. Transfection of each of the retinoblastoma family genes in neuroblastoma cells was able to induce neural differentiation, to inhibit 3 H-thymidine incorporation, and to down-regulate B-myb promoter activity. Conclusions. In conclusion, our data suggest a major contribution of retinoblastoma proteins, and especially of pRb2/p130, in Bmyb promoter regulation and demonstrate the induction of neural differentiation by p107 and pRb2/p130, suggesting a role of these proteins in triggering differentiation-specific genes. Med. Pediatr. Oncol. 36:104-107, 2001.
📜 SIMILAR VOLUMES
Human SK-N-AS neuroblastoma and U-87MG glioblastoma cell lines were found to secrete relatively high levels of glial cell line-derived neurotrophic factor (GDNF). In response to growth factors, cytokines, and pharmacophores, the two cell lines differentially regulated GDNF release. A 24-hr exposure
Signal transduction initiated by TGFb1 and OP-1 was studied in MG63 human osteosarcoma cells and in normal human bone cells (HBCs) in the presence of inhibitors of signal transduction events, using insulinlike growth factor binding protein-3 (IGFBP-3) production as an end point. Treatment of serum-f